Figures & data
Table 1 Baseline demographic and clinical characteristics of the study population stratified according to PKD subtype and dialysis status at the index date
Table 2 Healthcare consumption (in terms of the average annual number of pharmaceutical prescriptions, ambulatory care services, and hospital admissions) during the follow-up period stratified according to PKD subtype
Figure 1 Mean annual cost per PKD patient during the follow-up period. Costs are reported in euros (€).
Abbreviation: ADPKD, autosomal-dominant polycystic kidney disease; ARPKD, autosomal-recessive polycystic kidney disease; ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; PKD, polycystic kidney disease.
![Figure 1 Mean annual cost per PKD patient during the follow-up period. Costs are reported in euros (€).](/cms/asset/1650f1b0-2dc3-4fa4-99c7-9aca393f7020/dceo_a_130995_f0001_b.jpg)
Figure 2 Mean annual cost per patient during the follow-up period stratified according to PKD subtypes (ADPKD, ARPKD, unspecified genotype, or other). Costs are reported in euros (€).
Abbreviations: ADPKD, autosomal-dominant polycystic kidney disease; ARPKD, autosomal-recessive polycystic kidney disease; ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; NI, not issuable.
![Figure 2 Mean annual cost per patient during the follow-up period stratified according to PKD subtypes (ADPKD, ARPKD, unspecified genotype, or other). Costs are reported in euros (€).](/cms/asset/9835cf8e-4df3-41b0-8fd4-28b80cc00bc4/dceo_a_130995_f0002_b.jpg)